NEW MODEL TO QUANTIFY THE IN VITRO PHARMACOLOGICAL ACTIVITY OF BI-SPECIFIC ANTIBODIES IN HAEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
Primo, D. [1 ]
Martinez Cuadron, D. [2 ]
Montesinos, P. [2 ]
De la Serna, J. [3 ]
Ribera, J. Ma [4 ]
Vives, S. [4 ]
Bergua, J. [5 ]
Perez de Oteyza, J. [6 ]
Serrano, J. [7 ]
Gorrochategui, J. [1 ]
Vicente Ma, L. [1 ]
Gomez, C. [1 ]
Martinez Lopez, J. [3 ]
Hernandez, P. [1 ]
Ballesteros, J. [1 ]
机构：
[1] Vivia Biotech, Madrid, Spain
[2] Hosp Univ & Politecn La Fe Valencia, Valencia, Spain
[3] Hosp Univ 12 Octubre, Madrid, Spain
[4] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[5] Hosp San Pedro de Alcantara, Caceres, Spain
[6] Hosp Univ Sanchinarro, Madrid, Spain
[7] Hosp Univ Reina Sofia, Cordoba, Spain
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO-051
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [31] Multimodal cancer therapy involving oncolytic Newcastle disease virus, autologous immune cells and bi-specific antibodies
    Schirrmacher, Volker
    Fournier, Philippe
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [32] Geographic and racial disparities in bi-specific antibodies trials access for diffuse large B-cell lymphoma
    Shahzad, Moazzam
    Khalid, Muhammad Fareed
    Park, Robin
    Amin, Muhammad Kashif
    Anwar, Iqra
    Jaglal, Michael Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] Novel hCD3e mouse models for preclinical pharmacology studies of therapeutic bi-specific antibodies
    Xiang, Jie
    Li, Yanan
    Shen, Yuelei
    Guo, Yanan
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy
    Phung, Shee Kwan
    Miller, Jeffrey S.
    Felices, Martin
    MOLECULAR DIAGNOSIS & THERAPY, 2021, 25 (05) : 577 - 592
  • [35] Harnessing shape and bi-specific antibodies for improved cell-targeting efficiency of poly(ethylene glycol) capsules
    Song, Danzi
    Cui, Jiwei
    Ju, Yi
    Sun, Huanli
    Thurecht, Kristofer
    Caruso, Frank
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [36] A NOVEL IN VITRO METHOD TO QUANTIFY THE PHARMACOLOGY ACTIVITY OF BISPECIFIC ANTIBODIES IN HEMATOLOGICAL SAMPLES
    Primo, D.
    Hernandez, P.
    Ghia, P.
    de la Serna, J.
    Ribera, J. M.
    Vives, S.
    Bergua, J. M.
    Perez de Oteyza, J.
    Serrano, J.
    Gorrochategui, J.
    Vicente, M. L.
    Gomez, C.
    Martinelli, G.
    Simonetti, G.
    Ranghetti, P.
    Scarfo, L.
    Martinez-Cuadron, D.
    Montesinos, P.
    Martinez, J.
    Ballesteros, J.
    HAEMATOLOGICA, 2017, 102 : 448 - 448
  • [37] CD123 bi-specific antibodies in development in AML: What do we know so far?
    Slade, Michael J.
    Uy, Geoffrey L.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (04)
  • [38] Anti-HER-2xanti-CD3 Bi-specific Antibodies Inhibit Growth of HCT-116 Colorectal Carcinoma Cells in Vitro and in Vivo
    Ren, Hui
    Li, Jun
    Liu, Jing-Jing
    Guo, Hui-Ling
    Jiang, Tao
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (06) : 2795 - 2798
  • [39] Personalized ovarian cancer therapy using in vivo assembled bi-specific antibodies targeting Her2 and FSHR
    Bhojnagarwala, Pratik Sanjivkumar
    Ali, Ali Raza
    Frase, Drew
    Kulkarni, Abhijeet
    Bordoloi, Devivasha
    Weiner, David B.
    CANCER RESEARCH, 2022, 82 (12)
  • [40] A platform to deliver single and bi-specific Cas9/guide RNA to perturb genes in vitro and in vivo
    Li, Yi-Jia
    Chien, Sheng-Hsuan
    Huang, Rui
    Herrmann, Andreas
    Zhao, Qianqian
    Li, Pei-Chuan
    Zhang, Chunyan
    Martincuks, Antons
    Santiago, Nicole Lugo
    Zong, Katherine
    Swiderski, Piotr
    Okimoto, Ross A.
    Song, Mihae
    Rodriguez, Lorna
    Forman, Stephen J.
    Wang, Xiuli
    Yu, Hua
    MOLECULAR THERAPY, 2024, 32 (10) : 3629 - 3649
12345